LIMENCIN (capsaicin/methyl salicylate/menthol)


Drug overview for LIMENCIN (capsaicin/methyl salicylate/menthol):

Generic name: CAPSAICIN/METHYL SALICYLATE/MENTHOL
Drug class: Topical Local Anesthetics
Therapeutic class: Dermatological

Capsaicin is a transient receptor potential vanilloid 1 (TRPV1) receptor Lidocaine, a nonselective voltage-gated sodium channel inhibitor, is an agonist. amide-type local anesthetic.

Capsaicin is used topically for the treatment of pain. Capsaicin 8% topical Lidocaine is used topically for the treatment of pain. Various topical lidocaine products are commercially available.

Lidocaine 1.8% and 5% system is FDA-labeled for the treatment of neuropathic pain associated with postherpetic neuralgia (PHN) and for the treatment of neuropathic pain topical systems (i.e., patches) are FDA-labeled for the treatment of pain associated with diabetic peripheral neuropathy (DPN) of the feet. Capsaicin associated with postherpetic neuralgia (PHN).

Lidocaine is also available in various over-the-counter (OTC) topical preparations for the temporary is also available in various over-the-counter (OTC) topical preparations for the treatment of pain due to diabetic neuropathy, herpes zoster, or treatment of pain. arthritis; preparations available for OTC use contain lower concentrations of capsaicin (e.g., 0.025-0.15%) than the capsaicin 8% topical system.
DRUG IMAGES
  • No Image Available
    No Image Available
The following indications for LIMENCIN (capsaicin/methyl salicylate/menthol) have been approved by the FDA:

Indications:
Arthritic pain
Back pain
Sprains and strains


Professional Synonyms:
Sprains and joint or muscle strains
Sprains and muscle or joint strains
Sprains and muscle strains